Clinical Trial Update: VAG Versus Standard Chemotherapy With FLT3 Inhibitor in Adult Patients With FLT3-Mutated AML [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing the VAG regimen with a FLT3 inhibitor to standard chemotherapy in adults with FLT3-mutated acute myeloid leukemia, currently not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• FLT3 inhibitor
• VAG regimen

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: AML, Adult | Phase 3 | Status: NOT_YET_RECRUITING